Role of protein kinase A in regulating mitochondrial function and neuronal development: Implications to neurodegenerative diseases

Reviews in the Neurosciences

Volumn 26, Issue 3, 2015, Pages 359-370

  Dagda, Ruben K ^a   Das Banerjee, Tania ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

A kinase anchoring proteins; dendrites; mitochondrial dynamics; mitochondrial trafficking; neurodegeneration; protein kinase A

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; DOPAMINE; SCAFFOLD PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL SURVIVAL; CYTOSOL; DEGENERATIVE DISEASE; DENDRITE; DENDRITIC SPINE; DOPAMINE METABOLISM; ENZYME LOCALIZATION; HUMAN; HUNTINGTON CHOREA; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NERVE CELL PLASTICITY; NERVE FIBER; NERVE GROWTH; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; METABOLISM; MITOCHONDRION; NERVE CELL;

A KINASE ANCHOR PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENDRITES; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEURONS; SIGNAL TRANSDUCTION;

EID: 84930163256     PISSN: 03341763     EISSN: 21910200     Source Type: Journal    
DOI: 10.1515/revneuro-2014-0085     Document Type: Article

References (85)

1. Affaitati, A., Cardone, L., de Cristofaro, T., Carlucci, A., Ginsberg, M. D., Varrone, S., Gottesman, M. E., Avvedimento, E. V., and Feliciello, A. (2003). Essential role of A-kinase anchor protein 121 for cAMP signaling to mitochondria. J. Biol. Chem. 278, 4286-4294.
2. Aglah, C., Gordon, T., and Posse de Chaves, E. I. (2008). cAMP promotes neurite outgrowth and extension through protein kinase A but independently of Erk activation in cultured rat motoneurons. Neuropharmacology 55, 8-17.
3. Alto, N. M., Soderling, J., and Scott, J. D. (2002). Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics. J. Cell. Biol. 158, 659-668.
4. Andorfer, C. A. and Davies, P. (2000). PKA phosphorylations on tau: developmental studies in the mouse. Dev. Neurosci. 22, 303-309.
5. Arvanitis, D. N., Ducatenzeiler, A., Ou, J. N., Grodstein, E., Andrews, S. D., Tendulkar, S. R., Ribeiro-da-Silva, A., Szyf, M., and Cuello, A. C. (2007). High intracellular concentrations of amyloid-block nuclear translocation of phosphorylated CREB. J. Neurochem. 103, 216-228.
6. Ashrafi, G., Schlehe, J. S., LaVoie, M. J., and Schwarz, T. L. (2014). Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J. Cell. Biol. 206, 655-670.
7. Berthet, A., Margolis, E. B., Zhang, J., Hsieh, I., Zhang, J., Hnasko, T. S., Ahmad, J., Edwards, R. H., Sesaki, H., Huang, E. J., et al. (2014). Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons. J. Neurosci. 34, 14304-14317.
8. Bonelli, R. M. and Wenning, G. K. (2006). Pharmacological management of Huntington's disease: an evidence-based review. Curr. Pharm. Des. 12, 2701-2720.
9. Bui, M., Gilady, S. Y., Fitzsimmons, R. E., Benson, M. D., Lynes, E. M., Gesson, K., Alto, N. M., Strack, S., Scott, J. D., and Simmen, T. (2010). Rab32 modulates apoptosis onset and mitochondriaassociated membrane (MAM) properties. J. Biol. Chem. 285, 31590-31602.
10. Cardone, L., de Cristofaro, T., Affaitati, A., Garbi, C., Ginsberg, M. D., Saviano, M., Varrone, S., Rubin, C. S., Gottesman, M. E., Avvedimento, E. V., et al. (2002). A-kinase anchor protein 84/121 are targeted to mitochondria and mitotic spindles by overlapping amino-terminal motifs. J. Mol. Biol. 320, 663-675.
11. Cardone, L., Carlucci, A., Affaitati, A., Livigni, A., DeCristofaro, T., Garbi, C., Varrone, S., Ullrich, A., Gottesman, M. E., Avvedimento, E. V., et al. (2004). Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of src signaling. Mol. Cell. Biol. 24, 4613-4626.
12. Carlucci, A., Adornetto, A., Scorziello, A., Viggiano, D., Foca, M., Cuomo, O., Annunziato, L., Gottesman, M., and Feliciello, A. (2008). Proteolysis of AKAP121 regulates mitochondrial activity during cellular hypoxia and brain ischaemia. EMBO J. 27, 1073-1084.
13. Carnegie, G. K., Means, C. K., and Scott, J. D. (2009). A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 61, 394-406.
14. Chai, S., Li, M., Lan, J., Xiong, Z. G., Saugstad, J. A., and Simon, R. P. (2007). A kinase-anchoring protein 150 and calcineurin are involved in regulation of acid-sensing ion channels ASIC1a and ASIC2a. J. Biol. Chem. 282, 22668-22677.
15. Chalovich, E. M., Zhu, J. H., Caltagarone, J., Bowser, R., and Chu, C. T. (2006). Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells. J. Biol. Chem. 281, 17870-17881.
16. Chaturvedi, D., Cohen, M. S., Taunton, J., and Patel, T. B. (2009). The PKARI subunit of protein kinase A modulates the activation of p90RSK1 and its function. J. Biol. Chem. 284, 23670-23681.
17. Cherra, S. J. and Chu, C. T. (2008). Autophagy in neuroprotection and neurodegeneration: a question of balance. Future Neurol. 3, 309-323.
18. Cherra, S. J., 3rd, Kulich, S. M., Uechi, G., Balasubramani, M., Mountzouris, J., Day, B. W., and Chu, C. T. (2010). Regulation of the autophagy protein LC3 by phosphorylation. J. Cell. Biol. 190, 533-539.
19. Cookson, M. R. (2005). The biochemistry of Parkinson's disease. Annu. Rev. Biochem. 74, 29-52.
20. Copf, T. (2014). Developmental shaping of dendritic arbors in Drosophila relies on tightly regulated intra-neuronal activity of protein kinase A (PKA). Dev. Biol. 393, 282-297.
21. Dagda, R. K., Merrill, R. A., Cribbs, J. T., Chen, Y., Hell, J. W., Usachev, Y. M., and Strack, S. (2008). The spinocerebellar ataxia 12 gene product and protein phosphatase 2A regulatory subunit B2 antagonizes neuronal survival by promoting mitochondrial fission. J. Biol. Chem. 283, 36241-48.
22. Dagda, R. K., Gusdon, A. M., Pien, I., Strack, S., Green, S., Li, C., Van Houten, B., Cherra, S. J., 3rd, and Chu, C. T. (2011). Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease. Cell Death Differ. 18, 1914-1923.
23. Dagda, R. K., Pien, I., Wang, R., Zhu, J., Wang, K. Z., Callio, J., Banerjee, T. D., Dagda, R. Y., and Chu, C. T. (2014). Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A. J. Neurochem. 128, 864-877.
24. Davare, M. A., Dong, F., Rubin, C. S., and Hell, J. W. (1999). The A-kinase anchor protein MAP2B and cAMP-dependent protein kinase are associated with class C L-type calcium channels in neurons. J. Biol. Chem. 274, 30280-30287.
25. Devi, L. and Anandatheerthavarada, H. K. (2010). Mitochondrial trafficking of APP and synuclein: relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases. Biochim. Biophys. Acta 1802, 11-19.
26. Dickey, A. S. and Strack, S. (2011). PKA/AKAP1 and PP2A/B2 regulate neuronal morphogenesis via Drp1 phosphorylation and mitochondrial bioenergetics. J. Neurosci. 31, 15716-15726.
27. Eggers, C. T., Schafer, J. C., Goldenring, J. R., and Taylor, S. S. (2009). D-AKAP2 interacts with Rab4 and Rab11 through its RGS domains and regulates transferrin receptor recycling. J. Biol. Chem. 284, 32869-32880.
28. Feliciello, A., Gottesman, M. E., and Avvedimento, E. V. (2001). The biological functions of A-kinase anchor proteins. J. Mol. Biol. 308, 99-114.
29. Ginsberg, M. D., Feliciello, A., Jones, J. K., Avvedimento, E. V., and Gottesman, M. E. (2003). PKA-dependent binding of mRNA to the mitochondrial AKAP121 protein. J. Mol. Biol. 327, 885-897.
30. Giralt, A., Saavedra, A., Carreton, O., Xifro, X., Alberch, J., and Perez-Navarro, E. (2011). Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Hum. Mol. Genet. 20, 4232-4247.
31. Gomez, L. L., Alam, S., Smith, K. E., Horne, E., and Dell'Acqua, M. L. (2002). Regulation of A-kinase anchoring protein 79/150-cAMPdependent protein kinase postsynaptic targeting by NMDA receptor activation of calcineurin and remodeling of dendritic actin. J. Neurosci. 22, 7027-7044.
32. Goshima, Y., Ohsako, S., and Yamauchi, T. (1993). Overexpression of Ca2+/calmodulin-dependent protein kinase II in Neuro2a and NG108-15 neuroblastoma cell lines promotes neurite outgrowth and growth cone motility. J. Neurosci. 13, 559-567.
33. Gusdon, A. M. and Chu, C. T. (2010). To eat or not to eat: neuronal metabolism, mitophagy, and Parkinson's disease. Antioxid. Redox Signal. 14, 1979-1987.
34. Harada, A., Teng, J., Takei, Y., Oguchi, K., and Hirokawa, N. (2002). MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J. Cell. Biol. 158, 541-549.
35. Howells, D. W., Porritt, M. J., Wong, J. Y., Batchelor, P. E., Kalnins, R., Hughes, A. J., and Donnan, G. A. (2000). Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp. Neurol. 166, 127-135.
36. Huang, L. J., Durick, K., Weiner, J. A., Chun, J., and Taylor, S. S. (1997). D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. Proc. Natl. Acad. Sci. USA 94, 11184-11189.
37. Hwang, R. D., Wiemerslage, L., LaBreck, C. J., Khan, M., Kannan, K., Wang, X., Zhu, X., Lee, D., and Fridell, Y. W. (2014). The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease. Neurobiol. Dis. 69, 180-191.
38. Jiang, H., Cheng, D., Liu, W., Peng, J., and Feng, J. (2010). Protein kinase C inhibits autophagy and phosphorylates LC3. Biochem. Biophys. Res. Commun. 395, 471-476.
39. Johansson, C., Ballard, C., Hansson, O., Palmqvist, S., Minthon, L., Aarsland, D., and Londos, E. (2011). Efficacy of memantine in PDD and DLB: an extension study including washout and openlabel treatment. Int. J. Geriatr. Psychiatry 26, 206-213.
40. Kim, Y. T. and Wu, C. F. (1996). Reduced growth cone motility in cultured neurons from Drosophila memory mutants with a defective cAMP cascade. J. Neurosci. 16, 5593-5602.
41. Kinderman, F. S., Kim, C., von Daake, S., Ma, Y., Pham, B. Q., Spraggon, G., Xuong, N. H., Jennings, P. A., and Taylor, S. S. (2006). A dynamic mechanism for AKAP binding to RII isoforms of cAMPdependent protein kinase. Mol. Cell 24, 397-408.
42. Li, Z., Okamoto, K., Hayashi, Y., and Sheng, M. (2004). The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873-887.
43. Lin, J. T., Chang, W. C., Chen, H. M., Lai, H. L., Chen, C. Y., Tao, M. H., and Chern, Y. (2013). Regulation of feedback between protein kinase A and the proteasome system worsens Huntington's disease. Mol. Cell. Biol. 33, 1073-1084.
44. Livigni, A., Scorziello, A., Agnese, S., Adornetto, A., Carlucci, A., Garbi, C., Castaldo, I., Annunziato, L., Avvedimento, E. V., and Feliciello, A. (2006). Mitochondrial AKAP121 links cAMP and src signaling to oxidative metabolism. Mol. Biol. Cell 17, 263-271.
45. Ludvig, N., Mishra, P. K., and Jobe, P. C. (1992). Dibutyryl cyclic AMP has epileptogenic potential in the hippocampus of freely behaving rats: a combined EEG-intracerebral microdialysis study. Neurosci. Lett. 141, 187-191.
46. Matsuzaki, K., Yamakuni, T., Hashimoto, M., Haque, A. M., Shido, O., Mimaki, Y., Sashida, Y., and Ohizumi, Y. (2006). Nobiletin restoring â-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats. Neurosci. Lett. 400, 230-234.
47. Means, C. K., Lygren, B., Langeberg, L. K., Jain, A., Dixon, R. E., Vega, A. L., Gold, M. G., Petrosyan, S., Taylor, S. S., Murphy, A. N., et al. (2011). An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria. Proc. Natl. Acad. Sci. USA 108, E1227-E1235.
48. Merrill, R. A., Dagda, R. K., Dickey, A. S., Cribbs, J. T., Green, S. H., Usachev, Y. M., and Strack, S. (2011). Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1. PLoS Biol. 9, e1000612.
49. Merrill, R. A., Slupe, A. M., and Strack, S. (2013). N-terminal phosphorylation of protein phosphatase 2A/Bâ2 regulates translocation to mitochondria, dynamin-related protein 1 dephosphorylation, and neuronal survival. FEBS J. 280, 662-673.
50. Newhall, K. J., Criniti, A. R., Cheah, C. S., Smith, K. C., Kafer, K. E., Burkart, A. D., and McKnight, G. S. (2006). Dynamic anchoring of PKA is essential during oocyte maturation. Curr. Biol. 16, 321-327.
51. Pagliarini, D. J. and Dixon, J. E. (2006). Mitochondrial modulation: reversible phosphorylation takes center stage? Trends Biochem. Sci. 31, 26-34.
52. Papa, S. (2002). The NDUFS4 nuclear gene of complex I of mitochondria and the cAMP cascade. Biochim. Biophys. Acta 1555, 147-153.
53. Parisiadou, L., Yu, J., Sgobio, C., Xie, C., Liu, G., Sun, L., Gu, X. L., Lin, X., Crowley, N. A., Lovinger, D. M., et al. (2014). LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nat. Neurosci. 17, 367-376.
54. Perrino, C., Feliciello, A., Schiattarella, G. G., Esposito, G., Guerriero, R., Zaccaro, L., Del Gatto, A., Saviano, M., Garbi, C., Carangi, R., et al. (2010). AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. Cardiovasc. Res. 88, 101-110.
55. Plowey, E. D., Cherra, S. J., 3rd, Liu, Y. J., and Chu, C. T. (2008). Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J. Neurochem. 105, 1048-1056.
56. Poulopoulos, M., Cortes, E., Vonsattel, J. P., Fahn, S., Waters, C., Cote, L. J., Moskowitz, C., Honig, L. S., Clark, L. N., Marder, K. S., et al. (2012). Clinical and pathological characteristics of LRRK2 G2019S patients with PD. J. Mol. Neurosci. 47, 139-143.
57. Pugazhenthi, S., Wang, M., Pham, S., Sze, C. I., and Eckman, C. B. (2011). Downregulation of CREB expression in Alzheimer's brain and in Aâ-treated rat hippocampal neurons. Mol. Neurodegener. 6, 60.
58. Regland, B., Lehmann, W., Abedini, I., Blennow, K., Jonsson, M., Karlsson, I., Sjogren, M., Wallin, A., Xilinas, M., and Gottfries, C. G. (2001). Treatment of Alzheimer's disease with clioquinol. Dement. Geriatr. Cogn. Disord. 12, 408-414.
59. Reichardt, L. F. (2006). Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 361, 1545-1564.
60. Rodger, J., Goto, H., Cui, Q., Chen, P. B., and Harvey, A. R. (2005). cAMP regulates axon outgrowth and guidance during optic nerve regeneration in goldfish. Mol. Cell. Neurosci. 30, 452-464.
61. Rui, Y., Tiwari, P., Xie, Z., and Zheng, J. Q. (2006). Acute impairment of mitochondrial trafficking by â-amyloid peptides in hippocampal neurons. J. Neurosci. 26, 10480-10487.
62. Rydel, R. E. and Greene, L. A. (1988). cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. Natl. Acad. Sci. USA 85, 1257-1261.
63. Sampson, E. L., Jenagaratnam, L., and McShane, R. (2012). Metal protein attenuating compounds for the treatment of Alzheimer's dementia. Cochrane Database Syst. Rev. 5, CD005380.
64. Sandebring, A., Thomas, K. J., Beilina, A., van der Brug, M., Cleland, M. M., Ahmad, R., Miller, D. W., Zambrano, I., Cowburn, R. F., Behbahani, H., et al. (2009). Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS One 4, e5701.
65. Sarina, Yagi, Y., Nakano, O., Hashimoto, T., Kimura, K., Asakawa, Y., Zhong, M., Narimatsu, S., and Gohda, E. (2013). Induction of neurite outgrowth in PC12 cells by artemisinin through activation of ERK and p38 MAPK signaling pathways. Brain Res. 1490, 61-71.
66. Schwarz, T. L. (2013). Mitochondrial trafficking in neurons. Cold Spring Harb. Perspect. Biol. 5, pii: a011304.
67. Scorziello, A., Savoia, C., Sisalli, M. J., Adornetto, A., Secondo, A., Boscia, F., Esposito, A., Polishchuk, E. V., Polishchuk, R. S., Molinaro, P., et al. (2013). NCX3 regulates mitochondrial Ca2+ handling through the AKAP121-anchored signaling complex and prevents hypoxia-induced neuronal death. J. Cell Sci. 126, 5566-5577.
68. Sheng, B., Wang, X., Su, B., Lee, H. G., Casadesus, G., Perry, G., and Zhu, X. (2012). Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J. Neurochem. 120, 419-429.
69. Snow, B. J., Rolfe, F. L., Lockhart, M. M., Frampton, C. M., O'Sullivan, J. D., Fung, V., Smith, R. A., Murphy, M. P., Taylor, K. M., and Protect Study, G. (2010). A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov. Disord. 25, 1670-1674.
70. Strack, S. (2002). Overexpression of the protein phosphatase 2A regulatory subunit B-promotes neuronal differentiation by activating the MAP kinase (MAPK) cascade. J. Biol. Chem. 277, 41525-41532.
71. Tominaga-Yoshino, K., Kondo, S., Tamotsu, S., and Ogura, A. (2002). Repetitive activation of protein kinase A induces slow and persistent potentiation associated with synaptogenesis in cultured hippocampus. Neurosci. Res. 44, 357-367.
72. Tong, L., Thornton, P. L., Balazs, R., and Cotman, C. W. (2001). Betaamyloid-( 1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J. Biol. Chem. 276, 17301-17306.
73. Tong, L., Balazs, R., Thornton, P. L., and Cotman, C. W. (2004). Betaamyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J. Neurosci. 24, 6799-6809.
74. Unal, R., Pokrovskaya, I., Tripathi, P., Monia, B. P., Kern, P. A., and Ranganathan, G. (2008). Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein kinase C-activates binding of the C subunit of protein kinase A to the 3'-untranslated region of the lipoprotein lipase mRNA. Biochem. J. 413, 315-322.
75. van Spronsen, M., Mikhaylova, M., Lipka, J., Schlager, M. A., van den Heuvel, D. J., Kuijpers, M., Wulf, P. S., Keijzer, N., Demmers, J., Kapitein, L. C., et al. (2013). TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. Neuron 77, 485-502.
76. Verstreken, P., Ly, C. V., Venken, K. J., Koh, T. W., Zhou, Y., and Bellen, H. J. (2005). Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 47, 365-378.
77. Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., and Shelanski, M. (2002). Amyloid-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. USA 99, 13217-13221.
78. Wang, L., Sunahara, R. K., Krumins, A., Perkins, G., Crochiere, M. L., Mackey, M., Bell, S., Ellisman, M. H., and Taylor, S. S. (2001). Cloning and mitochondrial localization of full-length D-AKAP2, a protein kinase A anchoring protein. Proc. Natl. Acad. Sci. USA 98, 3220-3225.
79. Wang, Q. W., Rowan, M. J., and Anwyl, R. (2009). Inhibition of LTP by-amyloid is prevented by activation of 2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway. Neurobiol. Aging 30, 1608-1613.
80. Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y. L., Selkoe, D., Rice, S., Steen, J., LaVoie, M. J., and Schwarz, T. L. (2011a). PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893-906.
81. Wang, D., Yuen, E. Y., Zhou, Y., Yan, Z., and Xiang, Y. K. (2011b). Amyloid beta peptide-(1-42) induces internalization and degradation of 2 adrenergic receptors in prefrontal cortical neurons. J. Biol. Chem. 286, 31852-31863.
82. Xu, N., Engbers, J., Khaja, S., Xu, L., Clark, J. J., and Hansen, M. R. (2012). Influence of cAMP and protein kinase A on neurite length from spiral ganglion neurons. Hear. Res. 283, 33-44.
83. Yamamoto, M., Gotz, M. E., Ozawa, H., Luckhaus, C., Saito, T., Rosler, M., and Riederer, P. (2000). Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease. Biochim. Biophys. Acta 1535, 60-68.
84. Yang, L., Calingasan, N. Y., Lorenzo, B. J., and Beal, M. F. (2008). Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV. Exp. Neurol. 211, 311-314.
85. Yoshihara, M., Suzuki, K., and Kidokoro, Y. (2000). Two independent pathways mediated by cAMP and protein kinase A enhance spontaneous transmitter release at Drosophila neuromuscular junctions. J. Neurosci. 20, 8315-8322.